Company Financials

Merck Financials

United States dollar

business Merck Company Profile

Main Stock Listing

NYSE: MRK

Market Capitalization $265.89 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 14.08
Forward PE 12.87
Price to Sales TTM $4.14
Price to Book MRQ $5.11
Enterprise to Revenue 4.43
Enterprise to EBITDA 9.02

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 29.63%
Operating Margin 40.80%
Return on Assets TTM 13.76%
Return on Equity TTM 39.49%

Income Statement

Revenue TTM $64,234,999,808
Revenue per Share TTM $25.56
Quarterly Revenue Growth 3.70%
Gross Profit TTM $50,007,998,464
EBITDA $28,252,000,000
Net Income to Common TTM $19,033,999,360
Diluted EPS TTM $7.56
Quarterly Earnings Growth YoY 83.20%

Balance Sheet

Total Cash MRQ $18,214,000,640
Total Cash per Share MRQ $7.34
Total Debt MRQ $
Total Debt to Equity MRQ 79.71
Current Ratio MRQ 1.66
Book Value per Share MRQ $20.85

Cash Flow

Operating Cash Flow TTM $17,064,999,936
Levered Free Cash Flow TTM $14,527,875,072

MRK Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 2,487,348,810
Float Shares 2,478,026,480
Avg 10 Volume 12,434,547
Avg 30 Volume None
Shares Short 37,162,304
Short Ratio 2.34
Short % of Shares 1.67%
% Held by Insiders 0.06%
% Held by Institutions 80.30%

Stock Price Summary

Beta 0.30
Fifty Two Week Low $73.31
Fifty Two Week High $107.59
Fifty Two Week Change 6.87%
Day 50 MA $95.86
Day 200 MA $85.59

Dividends and Splits

Forward Annual Dividend Rate $3.40
Forward Annual Dividend Yield 3.19%
Trailing Annual Dividend Rate $3.28
Trailing Annual Dividend Yield 3.08%
Payout Ratio 42.86%
Dividend Date 2026-01-08
Ex Dividend Date 2025-12-15
Last Split Factor
Last Split Date 2021-06-03